我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

血栓形成及抗血栓药物研究的进展(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
1998年第1期
页码:
29-30,34
栏目:
综述
出版日期:
1998-01-01

文章信息/Info

Title:
-
作者:
张丽萍 综述　牟善初 审校
北京301医院南楼五病房 100853
Author(s):
-
关键词:
血栓形成　溶血栓药
Keywords:
-
分类号:
-
DOI:
-
文献标识码:
-
摘要:
-
Abstract:
-

参考文献/References

［1］Vermylen J. Role of platelet activation and fibrin formation in thrombogenesis. JACC, 1986; 8 (6 Suppl B) : 2B.

［2］Hawiger J. Formation and regulation of platelet and fibrin hemostatic plug. Hum Pathol, 1987; 18: 11.

［3］Ruan C. Monoclonal antibody to human platelet glycoprotein Ⅰ, Ⅱ. Effects on human platelet function. Br J Haematol, 1981; 49: 511.

［4］Zucker MB, Nachmias VT. Platelet activation.Atherosclerosis, 1985; 5 (1) : 2.

［5］Peerschke EJB. The platelet fibrinogen receptor. Semin Hematol, 1985; 22 (4) : 241.

[6]Verstraete M ,Dejana E, Fuster V. et al. An overview of antiplatelet and antithrombotic drugs. Haemostasis,1985; 15: 89.

[7] Fuster V , Adams PC, Badimon JJ. Platelet-inhibitor drugs role in coronary artery disease. Prog Cardiovasc Dis, 1987; 29 (5) : 325.

[8]Davies MJ , Thomas T. The pathological basis and microanatomy of occlusive coronary thrombus formation in human coronary arteriess. Philos Trans R Soc Lond ,1981; 294: 225.

[9]Hirsh J. Epidemiology and pathogenesis venous thrombosis. JACC, 1986; 8 (6 Suppl B) : 104B.

[10]Haslam RJ. Cyclic nucleotides in platelet function.Thromb Haemost, 1978; 40: 232.

[11]Stein B. Platelet inhibitor agents in cardiovascular disease: an update. JACC, 1989; 14: 813.

[12]Jaffe EA , Weksler BB. Recovery of endothdial cell prostcyclin production after inhibition by low doses of aspirin. J clin Invest, 1979; 63: 532.

[13]曹 萍.抗血栓药物. 国外医学药学分册, 1988; (2) : 82.

[14]Fitagerald GA. The biochemical pharmacology of thromboxane synthase inhibition in man. Circulation, 1985;72: 1194.

[15] Saussy DL Jr. thromboxane A2 and prostaglandin endoperoxide receptors in platelets and vascular smooth muscle. Circulation, 1985; 72: 1202.

[16]Fitagerald GA. Dipryridamole. N Engl. J Med , 1987;316: 1247.

[17]Mruk JS, Zoldhelyi P,Webster M , et al. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effect of r-hirudin,heperin, or asperin. Circulation, 1996; 93: 792.

[18]许景峰.抗血小板药: 噻氯匹啶.新药与临床, 1987;(3) : 188.

[19] Mousa SA ,Degrado WF,Mu DX. Oral antiplatelet. antithrombotic efficacy of DMP 728, a novel platelet GP Ⅱb/Ⅲ a antagonist. Circulation, 1996; 93: 537.

［20]王 斌.肝素生物作用的研究进展.国外医学输血及血液分册, 1986; 9 (2) : 117.

备注/Memo

备注/Memo:
(收稿1996-12-30；修回1997-10-05)
更新日期/Last Update: 1998-01-01